John Wiley & Sons, Inc. · NYSE:WLY
John Wiley & Sons — Q4 2026 Earnings Presentation
36 slides from John Wiley & Sons's earnings presentation, Jun 16, 2026
Slide 1: Q4 and Fiscal 2026 Earnings Review
Q4 and Fiscal 2026 Earnings Review JUNE 16, 2O26 NYSE:WLY
Slide 2: Safe Harbor Statement and Non-GAAP Financial Measures
SAFE HARBOR STATEMENT NON-GAAP FINANCIAL MEASURES This presentation contains certain forward-looking statements concerning the Wiley provides non-GAAP financial measures and performance results Company's operations, performance, and financial condition. Reliance should such as: not be placed on forw
Slide 3: Trusted Content and Intelligence for Innovation
Trusted content and intelligence for the advancement of science and innovation
Slide 4: Wiley Flywheel: Reinforcing Growth Engines
Wiley Flywheel: Reinforcing Growth Engines ▪ Publishing feeds content and data ▪ ▪ Content and data fuels AI and analytics AI and data analytics powers intelligence Content and Data ▪ Intelligence accelerates publishing Rich, curated datasets from world- class research across scientific, feeds techn
Slide 5: Wiley's Breakout Year
Wiley’s Breakout Year Unparalleled Partner Ecosystem Scaling in Research and AI & Data New Research Partnerships • Delivered mid-single digit growth in Research with record volume and strong recurring revenue • Acquired Emerald Publishing* to extend our scale in Research and content advantage in AI
Slide 6: Fiscal 2026 Performance
Fiscal 2026 Performance Record margins and strong double-digit growth in Free Cash Flow; record return to shareholders Adj. Revenue* GAAP EPS Adj. EPS* Adj. EBITDA* FCF 0% ▲$2.63 ▲15% ▲10% ▲55% $1,677M $4.16 $4.19 $440M $195M *Adjusted Revenue +1% including impact of currency. Adjusted Revenue, Adju
Slide 7: Multi-Year Execution and Value Creation
Multi-Year Execution and Value Creation * Adj. EBITDA (% margin) Adj. Operating Income (% margin) Free Cash Flow/ Conversion* $296 $195 $440 $251 $369 $398 17.7% 26.2% $195 15.1% $126 44% 24.0% $114 22.8% 12.1% 31% 32% FY24 FY25 FY26 FY24 FY25 FY26 FY24 FY25 FY26 Net Debt to EBITDA Share Repurchases
Slide 8: Wiley's Differentiators in the AI Economy
Wiley’s Differentiators in the AI Economy “Gold In, Gold Out:” AI is only as good as the authoritative content, data, and intelligence that fuels it Trusted, continually updating Leading position in high-demand World renowned CONTENT AND DATA KNOWLEDGE DOMAINS TRUST AND REPUTATION Provides access to
Slide 9: Research Growth Engine
Research Growth Engine
Slide 10: Research Publishing in the AI Knowledge Economy
Research Publishing in the AI Knowledge Economy Durable growth across economic cycles and through continuous technological and societal change Peer-review publishers set the global standard for scientific excellence, with longstanding journal brands and peer review networks forming an enduring moat
Slide 11: Wiley Research Momentum Accelerating
Wiley Research Momentum Accelerating Growth trajectory supported by strong moat and trends in global science and researcher productivity Driving market share gains with submissions up 25% and output 1 up 11%, well above market average Research Organic Growth Our Advanced portfolio is accelerating as
Slide 12: Emerald Transaction Rationale
Emerald Transaction Rationale Expands Research scale and deepens proprietary content across the AI-driven knowledge economy HIGHLIGHTS STRATEGIC RATIONALE Acquired Emerald for £337M, or USD $452M Strengthens scale advantage and deepens proprietary content in Research 1 Publishing, establishing or ex
Slide 13: Emerald at a Glance
Emerald at a Glance $85M+* 37-38%* 92% 99.6% FY26P Revenue FY26P Adj. EBITDA Margin Recurring Revenue Customer Retention • Founded in 1967; based in UK with 350 employees Robust Proprietary Content • Leading independent research publisher in social sciences addressing key societal challenges - econo
Slide 14: Emerald Accelerates All of Wiley's Value Drivers
Emerald Accelerates All of Wiley’s Value Drivers Wiley Value Drivers Emerald Accelerators ✓ Strategically expands Wiley’s portfolio to ~2,500 journals with leading positions across all key publishing areas Accelerate Research ✓ Complementary journal portfolio growing revenue at mid-single digits wor
Slide 15: Seamless Integration, Predictable Synergy Capture
Seamless Integration, Predictable Synergy Capture Leveraging Wiley’s proven playbook and world-class platform for integrating journal assets and businesses Phase 1: Post-Close Phase 2: Platform & Operations Integration (0-3 Months) (3-12 Months) • Day 1 close and integration governance established •
Slide 16: Welcoming Jessica Kowalski as New Research Leader
Welcoming Jessica Kowalski as New Research Leader Proven innovator from RELX, AWS, and Microsoft • Executive Vice President and General Manager, Research • Leads Wiley’s next phase of AI-enabled research publishing and partnerships across the global knowledge ecosystem • Brings more than two decades
Slide 17: AI and Data Analytics Growth Engine
AI and Data Analytics Growth Engine
Slide 18: Wiley Sits on a Deep Mine of Proprietary Data
Wiley sits on a very deep and untapped Our content mine of proprietary data advantages Published content Life Sciences and Healthcare Articles, journals, search Leading position in 150+ disease areas; top position in clinical outcomes assessments and medical synthesis Chemistry Leading position in 1
Slide 19: Wiley's AI Growth by the Numbers
Wiley’s AI Growth by the Numbers $110M+ Lifetime AI Revenue AI Revenue (recurring revenue rapidly scaling) Corporate Subscription Customers - 12 life sciences 19 - 4 engineering/materials/chemistry $49M $50M+ - 2 financial $8M $40M 2-3x - 1 agriculture and food science $1M 7 # of Top 10 Pharma Compa
Slide 20: AI & Data Analytics Growth Engine
AI & Data Analytics Growth Engine Three organic growth vectors leveraging existing assets, each with its own growth path 01 02 03 Database Solutions Applied Research Intelligence Audience Monetization Proprietary structured datasets A synthesis-first intelligence platform Scaling our unique data ass
Slide 21: Healthcare AI: Where Partnerships and Proprietary Data Converge
Healthcare AI: Where Partnerships and Proprietary Data Converge Unlocking Value in Existing Portfolio: Wiley partners with AWS Lifesciences to integrate peer- May 2025 reviewed research into Agentic AI framework Clinical Outcomes Assessments ▸ Hidden Gems: Wiley has one of the world's largest Wiley
Slide 22: Performance, Financial Position, and Outlook
Performance, Financial Position, and Outlook
Slide 23: Fourth Quarter 2026 Performance
Fourth Quarter 2026 Performance Strong momentum in core with margin up over 400 basis points Revenue* GAAP EPS Adj. EPS* Adj. EBITDA* 0% ▲$1.36 ▲22% ▲17% $448M $2.61 $1.67 $149M All numbers except GAAP EPS exclude impact of FX. ▪ Revenue performance driven by strong demand in Research Publishing (+5
Slide 24: Research Performance
Research Performance (millions) Q4 2026 Change Change CC Fiscal 2026 Change Change CC Research Publishing $259 7% 5% $966 5% 3% Research Solutions $37 (3%) (4%) $164 7% 6% Total Revenue $296 5% 4% $1,130 5% 4% Adjusted EBITDA $111 14% 13% $375 9% 8% Adjusted EBITDA Margin 37.7% 33.2% ▪ Research Publ
Slide 25: Learning Performance
Learning Performance (millions) Q4 2026 Change Change CC Fiscal 2026 Change Change CC Academic $96 (4%) (5%) $319 (4%) (5%) Professional $56 (9%) (10%) $228 (9%) (10%) Total Revenue $152 (6%) (7%) $547 (7%) (7%) Adjusted EBITDA $70 1% (1%) $208 (5%) (6%) Adjusted EBITDA Margin 46.1% 38.0% ▪ Academic
Slide 26: Reducing Costs and Driving Operational Excellence
Reducing Costs and Driving Operational Excellence Delivering margin expansion while reinvesting in strong, sustainable growth opportunities ▪ Tech transformation: reducing legacy and Corporate Expenses down 15% maintenance costs and shifting toward product and in Fiscal 2026 innovation work; retirin
Slide 27: Tech Transformation: Efficiency, Innovation, Growth
Tech Transformation: Efficiency, Innovation, Growth Driving permanent cost savings while shifting to new content and intelligence products AI-Native Innovation Structural Cost Savings Product-Led Growth • AI woven into core processes — not • Sustainable, structural savings from • Modern, integrated
Slide 28: Free Cash Flow and Balance Sheet
Free Cash Flow and Balance Sheet Strong execution and capital light model leads to greater capacity and flexibility to invest Free Cash Flow $195 Leverage Ratio (Net Debt to EBITDA) (FCF conversion ratio) 44% 1.8x 1.7x $126 $114 1.4x 31% 32% FY24 FY25 FY26 FY24 FY25 FY26 – Improved cash earnings – I
Slide 29: Portfolio and Disciplined Capital Allocation
Portfolio and Disciplined Capital Allocation Balancing high-return investments with returning cash to shareholders • Scaling our journal portfolio to drive continued market share gains, notably our $70M Advanced portfolio growing at strong double digits; multiple new Advanced journals launched or in
Slide 30: Fiscal 2027 Momentum
Fiscal 2027 Momentum Research driving mid-single digit growth with accelerating researcher productivity and strong publishing output, growth in FY27 Priorities renewals, market share gains, and society wins; Learning improving due • Accelerating buildout of AI and data to digital growth in Academic
Slide 31: Fiscal 2027 Outlook
Fiscal 2027 Outlook Metric Fiscal 2025 Fiscal 2026 Fiscal 2027 Outlook Organic Revenue Growth* Low to mid single digit growth (Research: mid-single digit growth) Adjusted EBITDA Margin 24.0% 26.2% 26.5% to 27.5% Adjusted EPS $3.64 $4.19 $4.60 to $5.05 Free Cash Flow $126M $195M $205M *Organic Revenu
Slide 32: Leading Wiley's Next Chapter of Compounding Growth
Leading Wiley’s Next Chapter of Compounding Growth Proven track records in driving innovation and quality growth across content, analytics, and AI Matthew Kissner Craig Albright Jessica Kowalski Jessica Mbaeliachi President & Chief Executive Officer EVP & Chief Financial Officer EVP & GM, Research S
Slide 33: Executive Summary
Executive Summary Accelerating progress in all major areas of value creation — Driving significant margin and cash flow expansion through multi-year execution and value creation — Driving strong growth and momentum in Research and AI & data analytics — Deploying capital strategically and continuousl
Slide 34: Thank You for Joining Us
Thank you for joining us For more information or follow-up: investors.wiley.com brian.campbell@wiley.com
Slide 35: Appendix - US GAAP to Non-GAAP Reconciliation
Appendix - US GAAP to Non-GAAP Reconciliation Reconciliation of US GAAP Earnings per Share to Non-GAAP Adjusted EPS Three Months Ended Year Ended April 30, April 30, 2026 2025 2026 2025 US GAAP Earnings Per Share - Diluted $ 2.61 $ 1.25 $ 4.16 $ 1.53 Adjustments: Restructuring and related charges 0.
Slide 36: Appendix - Net Income to Adjusted EBITDA
Appendix – Net Income to Adjusted EBITDA JOHN WILEY & SONS, INC. SUPPLEMENTARY INFORMATION (1)(2) RECONCILIATION OF US GAAP NET INCOME TO NON-GAAP EBITDA AND ADJUSTED EBITDA (in USD thousands) (unaudited) Three Months Ended Year Ended April 30, April 30, 2026 2025 2026 2025 Net Income $ 135,347 $ 68